Revenue base
Axio Forge
Non-GMP antibody lab · fee-for-service
High-throughput antibody lab generating fee-for-service revenue. Zero incremental capex for current growth.
Axio BioPharma is building the vendor-neutral data infrastructure for biomanufacturing — solving the handoff problem between sponsors and CDMOs that costs the industry months of delay per program.
Fragmented manufacturing data is the quiet tax on every biologics program.
Fragmented, siloed data between drug sponsors and CDMOs prevents AI from delivering real value and costs the industry months of delay per program.
Axio solves the data handoff problem by connecting and standardizing manufacturing data across organizations — without centralizing it. Data stays local to each partner; meaning is standardized across the network.
Non-GMP antibody lab · fee-for-service
High-throughput antibody lab generating fee-for-service revenue. Zero incremental capex for current growth.
Federated data platform · recurring subscription
Vendor-neutral infrastructure connecting manufacturing data across sponsors and CDMOs. Data stays local; meaning is standardized. High-margin recurring revenue.
Investors underwrite the services base. The Network provides the venture-scale return.
01 — Neutrality
Large CDMOs cannot host the network. Sponsors will not put proprietary process data on a competitor's platform. Axio's independence is the product.
02 — Standards
Each deployment compounds reusable connectors, mappings, and governance — making every additional site faster to onboard and late entry harder.
03 — Wet-lab engine
The lab generates the real manufacturing data that seeds the network, keeps the team close to execution, and pays its own way while the platform compounds.
Justin Byers
Founder, CEO
Biopharma PD and commercial leader focused on building biomanufacturing services from the ground up.
Brian Staats
Co-founder, CTO
Technology leader specializing in bioinformatics with 20+ years in modeling, data science, and engineering.
Dave Watrous
Chief Commercial Officer
Senior executive with 20+ years driving global growth and operational excellence across bioprocessing, SaaS, and CDMO organizations.
We will get back to you within two business days.